Baader Bank Aktiengesellschaft Boosts Stake in Danaher Co. (NYSE:DHR)

Baader Bank Aktiengesellschaft raised its stake in shares of Danaher Co. (NYSE:DHR) by 1.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 44,723 shares of the conglomerate’s stock after acquiring an additional 470 shares during the period. Danaher comprises about 0.7% of Baader Bank Aktiengesellschaft’s investment portfolio, making the stock its 20th biggest position. Baader Bank Aktiengesellschaft’s holdings in Danaher were worth $10,266,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. FMR LLC lifted its stake in shares of Danaher by 15.8% in the 3rd quarter. FMR LLC now owns 23,617,424 shares of the conglomerate’s stock valued at $6,566,116,000 after purchasing an additional 3,217,631 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Danaher by 3.0% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate’s stock valued at $1,417,342,000 after buying an additional 148,251 shares during the last quarter. Fisher Asset Management LLC increased its position in Danaher by 2.6% in the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate’s stock valued at $1,265,725,000 after acquiring an additional 116,299 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate’s stock worth $996,141,000 after purchasing an additional 535,254 shares in the last quarter. Finally, Montrusco Bolton Investments Inc. lifted its stake in shares of Danaher by 0.6% in the fourth quarter. Montrusco Bolton Investments Inc. now owns 1,715,826 shares of the conglomerate’s stock valued at $382,936,000 after purchasing an additional 9,942 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on DHR. Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price objective for the company in a research report on Thursday, October 31st. TD Cowen upped their price target on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. UBS Group decreased their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Scotiabank began coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price target for the company. Finally, Citigroup dropped their target price on shares of Danaher from $305.00 to $285.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Six equities research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $284.14.

Danaher Trading Down 10.0 %

DHR opened at $223.12 on Thursday. Danaher Co. has a twelve month low of $223.00 and a twelve month high of $281.70. The company has a fifty day moving average of $236.09 and a 200-day moving average of $253.66. The stock has a market cap of $161.15 billion, a PE ratio of 42.58, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last posted its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same quarter in the prior year, the firm earned $2.09 earnings per share. On average, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s dividend payout ratio (DPR) is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.